FDA approves CELG, NVS ADHD drug

The FDA granted marketing approval to Celgene (CELG) and Novartis (NVS; SWX:NOVN) for dexmethylphenidate to treat attention deficit/hyperactivity disorder (ADHD). The drug is a single, active isomer o...